Preparation and characterization of solid lipid nanoparticles - A review

Current Drug Discovery Technologies

Volumn 9, Issue 1, 2012, Pages 2-16

  Parhi, Rabinarayan ^a   Suresh, Padilama ^a  

^a GITAM UNIVERSITY   (India)

Author keywords

Homogenization; Raman spectra; Solid lipid nanoparticle; Ultrasonication

Indexed keywords

BOVINE SERUM ALBUMIN; CERAMIDE; CLOBETASOL PROPIONATE; CLOTRIMAZOLE; CYCLOSPORIN A; DIAZEPAM; DOXORUBICIN; GONADORELIN; HYDROCORTISONE; INDOMETACIN; INSULIN; ISONIAZID; ISOTRETINOIN; KETOPROFEN; MIFEPRISTONE; NAVELBINE; NITRENDIPINE; ORIDONIN; PACLITAXEL; PODOPHYLLOTOXIN; PYRAZINAMIDE; RETINOL; RIFAMPICIN; SOLID LIPID NANOPARTICLE; STAVUDINE; TRIAMCINOLONE ACETONIDE; TRIPTOLIDE; UNINDEXED DRUG; VERAPAMIL; VINPOCETINE;

AQUEOUS SOLUTION; ATOMIC FORCE MICROSCOPY; CRYSTALLIZATION; DILUTION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; EMULSION; ENTHALPY; EVAPORATION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FIELD FLOW FRACTIONATION; LIGHT SCATTERING; LIPID ANALYSIS; LIPOPHILICITY; MELTING POINT; MICROEMULSION; MICROFLUIDIC ANALYSIS; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; SUPERCRITICAL FLUID EXTRACTION; ULTRASOUND; ZETA POTENTIAL;

BIOLOGICAL AVAILABILITY; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; LIPIDS; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 84858258991     PISSN: 15701638     EISSN: 18756220     Source Type: Journal    
DOI: 10.2174/157016312799304552     Document Type: Review

References (123)

1. Müller RH, Menhert K. Solid lipid nanoparticles (SLN)-An alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1995; 41: 62-9.
2. Collins-Gold L, Feichtinger N, Warnheim T. Are lipid emulsions the drug delivery solution? Mod Drug Discov 2000; 3: 44-8.
3. Kumar V, Banker GS. In: Target-Oriented Drug-Delivery systems; Banker GS, Rhodes CT, Ed. Modern Pharmaceutics. Marcel Dekker, INC: New York, Basel. pp. 529-86.
4. Utreja S, Jain NK. In: Solid Lipid Naoparticles; Jain NK, Ed. Advances in controlled and novel drug delivery. CBS publishers and distributors, New Delhi, 2001; pp. 408-9.
5. Allen TM, Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. Fed Eur Biochem Society 1987; 223: 42-6.
6. Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev 2007; 59: 454-77. (Pubitemid 47259226)
7. Date AA, Joshi MD, Patravale VB. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 2007; 59: 505-21. (Pubitemid 47259228)
8. Siekmann B, Westesen K. Sub-micron sized parenteral carrier systems based on solid lipids. Pharm Pharmacol Letters 1992; 1: 123-6.
9. Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. US Patent 5,250,236, 1993.
10. Schwarz C, Mehnert W, Lucks JS, Muller RH. Solid lipid nanoparticles (SLN) for controlled drug delivery: I. Production, characterization and sterilization. J Control Release 1994; 30: 83-96. (Pubitemid 24173181)
11. Westesen K, Siekmann B, Koch MHJ. Investigations on the physical state of lipid nanoparticles by synchroton radiation X-ray diffraction. Int J Pharm 1993; 93: 189-99. (Pubitemid 23181296)
12. Cavalli R, Marengo E, Rodriguez L, Gasco MR. Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm 1996; 43: 110-15. (Pubitemid 26173946)
13. Bunjes H, Westesen K, Koch MHJ. Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 1996; 129: 159-73. (Pubitemid 26098737)
14. Gasco MR. Solid lipid nanospheres from warm microemulsions. Pharm Technol Eur 1997; 9: 52-8.
15. Heiati H, Phillips NC, Tawashi R. Evidence for phospholipid bilayer formation in solid lipid nanoparticles formulated with phospholipid and triglyceride. Pharm Res 1996; 13: 1406-10. (Pubitemid 26344990)
16. Vringer T, Ronde HAG. Preparation and structure of water-in-oil cream containing lipid nanoparticles. J Pharm Sci 1995; 84: 466- 72.
17. Sjostrom B, Kaplun A, Talmon Y, Cabane B. Structure of nanoparticles prepared from oil-in-water emulsions. Pharm Res 1995; 12: 39-48.
18. Pinto JF, Müller RH. Pellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugs. Pharmazie 1999; 54: 506-9. (Pubitemid 29342658)
19. Dingler A, Blum RP, Niehus H, Gohla S, Muller RH. Solid lipid nanoparticles (SLN/Lipopearls)-a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. J Microencapsulation 1999; 16: 751-67. (Pubitemid 29478954)
20. Demirel M, Yazan Y, Muller RH, Kilic F, Bozan B. Formulation and in vitro-in vivo evaluation of piribedil solid lipid particles. J Microencapsulation 2001; 18: 359-71. (Pubitemid 32285032)
21. Wissing SA, Müller RH. Solid lipid nanoparticles as carrier for sunscreens: in vitro release and in vivo skin penetration. J Control Release 2002; 81: 225-33. (Pubitemid 34607144)
22. Liu W, Hu M, Liu W, Xue C, Xu H, Yang XL. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm 2008; 364: 135-41.
23. Küchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, Schäfer-Korting M, Kramer KD. Nanoparticles for skin penetration enhancement -A comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm 2009; 71: 243-50.
24. Jensena LB, Magnussson E, Gunnarsson L, Vermehren C, Nielsen HM, Petersson K. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. Int J Pharm 2010; 390: 53-60.
25. Cavalli R, Morel S, Gasco MR, Chetoni P, Saettone MF. Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair. Int J Pharm 1995; 107: 243-6.
26. Cavalli R, Peira E, Caputo O, Gasco MR. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with βcyclodextrins. Int J Pharm 1999; 182: 59-69. (Pubitemid 29229795)
27. Li HL, Zhao XB, Ma YK, Zhai GX, L, LB, Lou HX. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009; 133: 238-44
28. Gasco MR. Solid lipid nanoparticles for drug delivery. Pharm Tech Eur 2001; 13: 32-41.
29. Cavalli R, Gasco MR, Chetoni P, Burgalassi S, Saettone MF. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 2002; 238: 241-5. (Pubitemid 34457892)
30. Jenning V, Schafer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 2000; 66: 115-26. (Pubitemid 30160850)
31. Lippacher A, Müller RH, Mader K. Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Int J Pharm 2000; 196: 227-30. (Pubitemid 30105749)
32. Olbrich C, Kayser O, Muller RH. Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity. Int J Pharm 2002; 237: 119-28. (Pubitemid 34310485)
33. Sznitowska M, Gajewska M, Janicki S, Radwanska A, Lukowski G. Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur J Pharm Biopharm 2001; 52: 159-63. (Pubitemid 32755894)
34. Souto EB, Wissing SA, Barbosa CM, Muller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm 2004; 278: 71-7. (Pubitemid 38670438)
35. Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: Influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm 2007; 335: 167-75. (Pubitemid 46482862)
36. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 2007; 328: 191-5. (Pubitemid 44880576)
37. Attama AA, Muller-Goymann CC. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Int J Pharm 2007; 334: 179-89. (Pubitemid 46400318)
38. Jee JP, Lim SJ, Park JS, Kim CK. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles. Eur J Pharm Biopharm 2006; 63: 134-9.
39. Lim SJ, Kim CK. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002; 243: 135-46.
40. Jenning V, Thunemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000; 199: 167-77. (Pubitemid 30236188)
41. Heiati H, Tawashi R, Phillips NC. Solid lipid nanoparticles as drug carriers II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice. Int J Pharm 1998; 174: 71-80. (Pubitemid 28486991)
42. Müller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161-76.
43. Shegokar R, Singh KK, Müller RH. Production & stability of stavudine solid lipid nanoparticles- From lab to industrial scale. Int J Pharm 2011; 416(2): 461-70.
44. Muller RH, Runge S, Ravelli V, Mehnert W, Thunemann AF, Souto EB. Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals. Int J Pharm 2006; 317: 82-9. (Pubitemid 43866342)
45. Zhang Q, Yie G, Li Y, Yang Q, Nagai T. Studies on the cyclosporin A loaded stearic acid nanoparticles. Int J Pharm 2000; 200: 153-9. (Pubitemid 30364902)
46. You J, Wan F, Cui FD, Sun Y, Du Y, Hu FQ. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles. Int J Pharm 2007; 343: 270-6. (Pubitemid 47321031)
47. Miglietta A, Cavalli R, Bocca C, Gabriel L, Gasco MR. Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int J Pharm 2000; 210: 61-7. (Pubitemid 32332642)
48. Siekmann B, Westesen K. Melt-homogenized solid lipid nanoparticles stabilized by the nonionic surfactant tyloxapol. I. Preparation and particle size determination. J Pharm Pharmacol 1994; 3: 194-7.
49. Ma QH, Xia Q, Lu YY, et al. Preparation of tea polyphenolsloaded solid lipid nanoparticles based on the phase behaviors of hot microemulsions. Solid State Phenomena 2007; 121-123: 705-8. (Pubitemid 351150784)
50. Marengo E, Cavalli R, Caputo O, Rodriguez L, Gasco MR. Scaleup of the preparation process of solid lipid nanospheres, Part I. Int J Pharm 2000; 205: 3-13.
51. Heydenreich AV, Westmeier R, Pedersen N, Poulsen HS, Kristensen HG. Preparation and purification of cationic solid lipid nanospheres-effects on particle size, physical stability and cell toxicity. Int J Pharm 2003; 254: 83-7. (Pubitemid 36259816)
52. Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm 2007; 337: 299-306. (Pubitemid 46756048)
53. Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanoparticles (SLN). Int J Pharm 2002; 241: 341-4. (Pubitemid 34718035)
54. Cavalli R, Marengo E, Rodriguez L, Gasco MR. Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm 1996; 43: 110-5. (Pubitemid 26173946)
55. Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004; 56: 1257-72. (Pubitemid 38510473)
56. Xie FM, Zeng K, Li GF, Lin ZF, Sun LD. Preparation of stearic acid solid lipid nanoparticles containing podophyllotoxin. Di Yi Jun Yi Da Xue Xue Bao 2005; 25: 99-101.
57. Jin C, Bai L, Wu H, Tian F, Guo G. Radiosensitization of paclitaxel, etanidazole and paclitaxel + etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials 2007; 28: 3724-30. (Pubitemid 46855881)
58. Lemos-Senna E, Wouessidjewe D, Lesieur S, Duchene D. Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading. Int J Pharm 1998; 170: 119-28. (Pubitemid 28473252)
59. Shahgaldiana P, Quattrocchia L, Gualberta J, Colemana AW, Goreloff P. AFM imaging of calixarene based solid lipid nanoparticles in gel matrices. Eur J Pharm Biopharm 2003; 55: 107-13. (Pubitemid 36120502)
60. Tan CP, Nakajima M. β-Carotene nanodispersions: preparation, characterization and stability evaluation. Food Chem 2005; 92: 661-71. (Pubitemid 40544811)
61. Zhang N, Ping Q, Huang G, Xu W, Cheng Y, Han X. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Int J Pharm 2006; 327: 153-9. (Pubitemid 44667334)
62. Trotta M, Chirio D, Cavalli R, Peira E. Hydrophilic microspheres from Water-in-Oil emulsions by the water diffusion technique. Pharm Res 2004; 21: 1445-9. (Pubitemid 39149660)
63. Kawashima Y, Yamamoto H, Takeuchi H, Hino T, Niwa T. Properties of a peptide containing DL-lactide: glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm 1998; 45: 41-8. (Pubitemid 28248254)
64. Pandey R, Sharma S, Khuller GK. Oral solid lipid nanoparticle-based antitubercular chemotherapy. Tuberculosis 2005; 85: 415-20. (Pubitemid 41617396)
65. Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 2004; 273: 29-35. (Pubitemid 38317037)
66. Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003; 257: 153-60. (Pubitemid 36507041)
67. Trotta M, Cavalli R, Carlotti ME, Battaglia L, Debernardi F. Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique. Int J Pharm 2005; 288: 281-8. (Pubitemid 40038581)
68. Hu FQ, Yuan H, Zhang HH, Fang M. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 2002; 239: 121-8. (Pubitemid 34615801)
69. Quintanar-Guerrero, Tamayo-Esquivel D, Ganem-Quintanar A, Allemann E, Doelker E. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur J Pharm Sci 2005; 26: 211-8.
70. Reithmeier H, Herrmann J, Gopferich A. Lipid microparticles as a parenteral controlled release device for peptides. J Control Release 2001; 73: 339-50. (Pubitemid 32539261)
71. Reithmeier H, Herrmann J, Gopferich A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 2001; 218: 133-43. (Pubitemid 32406164)
72. Mehnert W, Mader K. Solid lipid nanoparticles Production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165-96. (Pubitemid 32324113)
73. Mei Z, Li X, Wu Q, Hu S, Yang X. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticles. Pharm Res 2005; 51: 345-51. (Pubitemid 40430808)
74. Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm 2005; 304: 231-8. (Pubitemid 41427665)
75. Kim BD, Na K, Choi HK. Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur J Pharm Sci 2005; 24: 199-205. (Pubitemid 40127550)
76. Zhang D, Tan T, Gao L. Preparation of oridonin-loaded solid lipid nanoparticles and studies of them in vitro and in vivo. Nanotech 2006; 17: 5821-8. (Pubitemid 46069957)
77. Hou DZ, Xie CS, Huang KJ, Zhu CH. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003; 24: 1781-5. (Pubitemid 36184733)
78. Luo YF, Chen DW, Ren LX, Zhao XL, Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release 2006; 114: 53-9. (Pubitemid 44144503)
79. Cortesia R, Espositoa E, Lucab G, Nastruzzib C. Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002; 23: 2283-94.
80. Jaganathan KS, Rao YUB, Singh P, et al. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly (d,l-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm 2005; 294: 23-32. (Pubitemid 40462320)
81. Garcia-Fuentes M, Torres D, Alonso MJ. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids and Surfaces B: Biointerfaces 2002; 27: 159-68
82. Utada AS, Lorenceau E, Link DR, Kaplan PD, Stone HA, Weitz DA. Microcapillary Device Monodisperse Double Emulsions Generated from a microcapillary device. Science 2005; 308: 537-41 (Pubitemid 40570581)
83. Liu J, Gong T, Wang C, Zhong Z, Zhang Z. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholinebased mixed micelles: preparation and characterization. Int J Pharm 2007; 340: 153-62. (Pubitemid 47044961)
84. Hatziantoniou S, Deli G, Nikas Y, Demetzos C, Papaioannou GT. Scanning electron microscopy study on nanoemulsions and solid lipid nanoparticles containing high amounts of ceramides. Micron 2007; 38: 819-23. (Pubitemid 47554621)
85. Liu J, Gong T, Fu H, et al. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008; 356: 333-44.
86. Charcosset C, El-Harati A, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 2005; 108: 112-20. (Pubitemid 41476679)
87. El-Harati AA, Charcosset C, Fessi H. Influence of the formulation for Solid Lipid Nanoparticles prepared with a Membrane Contactor. Pharm Devel Tech 2006; 11: 153-7. (Pubitemid 43879938)
88. Charcosset C, El-Harati AA, Fessi H. A membrane contactor for the preparation of solid lipid nanoparticles. Desalination 2006; 200: 570-1. (Pubitemid 44173462)
89. Schubert MA, Müller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles- evaluation of the method and process parameters. Eur J Pharm Biopharm 2003; 55: 125-31. (Pubitemid 36120504)
90. Jovanovic N, Bouchard A, Hofland GW, Witkamp GJ, Crommelin DJA, Jiskoot W. Stabilization of Proteins in Dry Powder Formulations Using Supercritical Fluid Technology. Pharm Res 2004; 21: 1955-69. (Pubitemid 40941214)
91. Chattopadhyay P, Shekunov BY, Yim D, Cipolla D, Boyd B, Farr S. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007; 59: 444-53. (Pubitemid 47259225)
92. He WZ, Suo QL, Jiang ZH, Shan A, Hong HL. Precipitation of ephedrine by SEDS process using a specially designed prefilming atomizer. J Supercritical Fluids 2004; 31: 101-10.
93. Santos IRD, Richard J, Pech B, Thies, Benoit JP. Microencapsulation of protein particles within lipids using a novel supercritical fluid process. Int J Pharm 2002; 242: 69-78.
94. Jung J, Perrut M. Particle design using supercritical fluids: Literature and patent survey. J Supercritical Fluids 2001; 20: 179-219. (Pubitemid 32607129)
95. Bouchard A, Jovanovic N, Jiskoot W, et al. Lysozyme particle formation during supercritical fluid drying: Particle morphology and molecular integrity. J Supercritical Fluids 2007; 40: 293-307. (Pubitemid 46162137)
96. Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007; 59: 478-90. (Pubitemid 47260710)
97. Zhang S, Yun J, Shen S, et al. Formation of solid lipid nanoparticles in a microchannel system with a cross-shaped junction. Chem Eng Science 2008; 63: 5600-5.
98. Zhang S, Shen S, Chen Z, et al. Preparation of solid lipid nanoparticles in co-flowing microchannels. Chem Eng J 2008; 144: 324-8.
99. Yun J, Zhang S, Shen S, Chen Z, Yao K, Chen J. Continuous production of solid lipid nanoparticles by liquid flow-focusing and gas displacing method in microchannels. Chem Eng Science 2009; 64: 4115-22
100. Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev 2007; 59: 411-8. (Pubitemid 47259223)
101. Seetapan N, Bejrapha P, Srinuanchai W, Ruktanonchai UR. Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). Micron 2010; 41: 51-8.
102. Anger S, Caldwell K, Niehus H, Müller RH. High resolution size determination of 20 nm colloidal gold particles by sedimentation flow fractionation. Pharm Res 1999; 16: 1743-7. (Pubitemid 29530408)
103. Anger S, Mehnert W, Caldwell K, Müller RH. High Resolution Determination of Adsorption Layer Mass on Particles by Sedimentation Field-Flow Fractionation. Proceding of the 2nd World Meeting APGI/APV, 1998, pp. 643-4.
104. Anger S, Caldwell K, Mehnert W, Müller RH. Coating of nanoparticles: analysis of adsorption using sedimentation flow fractionation (SdFFF), Proc Int Symp Control Release Bioact Mater 1999, 26.
105. Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm 2006; 314: 56-62.
106. Ney P. Zetapotentiale und flotierbarkeit von mineralien. Springer: New York, 1973.
107. Libster D, Aserin A, Wachtel E, Shoham G, Garti N. Surfactant Science Series. Garti N, Sato K. Ed. Crystallization and Polymorphism of Fats and Fatty Acids. Marcel Dekker: New York, 1988: 31: pp. 3-87.
108. Martin A, Swarbrick J, Cammarata A. In: Lea.; Febiger. Eds.; States of matter and phase equilibria. Philadelphia: Physical Pharmacy, 1983. pp. 62-92.
109. Müller RH, Runge SA, Ravelli V, Thunemann A, Mehnert W, Souto EB. Cyclosporine-loaded solid lipid nanoparticles (SLN): Drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm 2008; 68: 535-44. (Pubitemid 351318197)
110. Eldem T, Speiser P, Altorfer H. Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy. Pharm Res 1991; 8: 178-84.
111. Jenning V, Gysler A, Schafer-Korting M, Gohla SH. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 2000; 49: 211-8. (Pubitemid 30229868)
112. Bunjes H, Unruh T. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev 2007; 59: 379-402 (Pubitemid 47259221)
113. Westesen K, Siekmann B, Koch MHJ. Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int J Pharm 1993; 93: 189-99. (Pubitemid 23181296)
114. Kheradmandnia S, Vasheghani-Farahani E, Nosrati M, Atyabi, F. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomedicine 2010; 6: 753-9.
115. L. Hernqvist. In: Crystal structures of fats and fatty acids. Garti N, Sato K, Ed. Crystallization and Polymorphism of Fats and Fatty Acids. Marcel Dekker: New York and Basel, 1998; pp. 97-137.
116. Pratiwi D, Fawcet JP, Gordon KC, Rades T. Quantitative analysis of polymorphic mixture of ranitidine hydrochloride of Raman spectra and principal component analysis. Eur J Pharm Biopharm 2002; 54: 337-41. (Pubitemid 35341835)
117. Tandon P, Forster G, Neubert R, Wartewig S. Phase transitions in oleic acid as studied by X-ray diffraction and FT-Raman spectroscopy. J Mol Struct 2005; 524: 201-15.
118. Vankeirsbilck T, Vercauteren A, Baeyens W, et al. Applications of Raman spectroscopy in pharmaceutical analysis. TRAC Trends Anal Chem 2002; 21: 869-77. (Pubitemid 35463178)
119. Wartewig S, Neubert RHH. Pharmaceutical applications of Mid-IR and Raman spectroscopy. Adv Drug Deliv Rev 2005; 57: 1144-70. (Pubitemid 40803442)
120. Dollish FR, Fateley W, Bentley F. Charecteristics Roman Frequencies of Organic Compounds. 3rd Ed. Wiley-Interscience, New York, 1973.
121. Boistelle R. In: Fundamentals of nucleation and crystal growth; Garti N, Sato K, Ed. Crystallization and Polymorphism of Fats and Fatty Acids, Marcel Dekker, INC; New York, Basel, 1988; pp.189-226.
122. Zimmermann E, Liedtke S, Müller RH, Mader K. H-NMR as a method to characterize colloidal carrier systems. Proc Int Symp Control Release Bioact Mater 1999; 26: 591-2.
123. Subedi RK, Kanga KW, Choi H. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur J Pharm Sciences 2009; 37: 508-13.